As Q1FY26 earnings season heats up, Swiggy, Mahindra & Mahindra, ITC, Tata Power, Sun Pharma, UPL, and Maruti Suzuki are set ...

Cipla Ltd ( ($IN:CIPLA) ) has provided an announcement. Cipla Ltd has released its unaudited financial results for the quarter ended June 30, ...

This renewed focus comes amid growing concerns over unchecked price hikes in commonly used medicines. While essential ...

In a written reply to the Lok Sabha, Anupriya Patel shared that government schemes promoted domestic manufacturing of medical ...

Panaji: The India-UK free trade agreement (FTA) will significantly benefit Goa’s pharmaceutical companies, tourism sector, ...

A strategic blueprint to build India’s consulting champions — through fairer procurement rules and structural support — to ...

India has disbursed over Rs 1,008 crore in incentives to domestic firms to bolster Active Pharmaceutical Ingredient (API) production, significantly reducing reliance on Chinese ...

India has the potential to turn that principle into practice by making the next generation of therapies not only practical but also accessible and affordable. If it succeeds, India won’t just lead the ...

YANGON: The Embassy of India in Myanmar, in collaboration with the India-Myanmar Chamber of Commerce and Industry (IMCCI), hosted the "PHARMA CONNECT 2025" event on the evening of July 25 at the Pan ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...

Indian pharma a formidable competitor for global manufacturing: Sameer Hiremath: Nandita Vijayasimha, Bengaluru Saturday, July 26, 2025, 08:00 Hrs [IST] Indian pharma presents an ...

Commerce Secretary Sunil Barthwal on Friday said that India can face competition and is not the ‘tariff king’, as India’s ...